Melanoma Institute Australia
North Sydney, New South Wales, Australia
Educational institution in Wollstonecraft, New South Wales
The Poche Centre, 40 Rocklands Rd, Wollstonecraft NSW 2065
About Melanoma Institute Australia
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Melanoma Institute Australia
During the past decade, Melanoma Institute Australia conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 9 clinical trials were completed, i.e. on
average, 45% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 5 clinical trials were completed. i.e. 71.4%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Multicenter Selective Lymphadenectomy Trial II (MSLT-II)
2004-09-30
2019-09-30
Completed
1,939
A Study of Vemurafenib in Participants With Metastatic Melanoma
2011-03-01
2016-02-24
Completed
3,219
Whole Brain Radiotherapy Following Local Treatment of Intracranial Metastases of Melanoma
2007-10-01
2022-06-01
Unknown status
220
A Phase Ib/II Study of LGX818 in Combination With MEK162 in Adult Patients With BRAF Dependent Advanced Solid Tumors
2012-05-30
2023-03-09
Completed
189
A Study of Vemurafenib Adjuvant Therapy in Participants With Surgically Resected Cutaneous BRAF-Mutant Melanoma
2012-09-24
2018-07-13
Completed
498
A Study Comparing Vemurafenib Versus Vemurafenib Plus Cobimetinib in Participants With Metastatic Melanoma
2013-01-08
2019-07-21
Completed
495
Study Comparing the Efficacy of MEK162 Versus Dacarbazine in Unresectable or Metastatic NRAS Mutation-positive Melanoma
2013-07-12
2019-06-04
Completed
402
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Melanoma Institute Australia" #1 sponsor was "Hoffmann-La Roche" with 7 trials, followed by "Melanoma and Skin Cancer Trials Limited" with 5 trials
sponsored, "Melanoma Institute Australia" with 4 trials sponsored, "Pfizer" with 4 trials sponsored and "Bristol-Myers Squibb"
with 4 trials sponsored. Other sponsors include 4 different institutions and
companies that sponsored additional 13 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Melanoma Institute Australia"
#1 collaborator was "Merck Sharp & Dohme LLC" with 5 trials as a collaborator, "Bristol-Myers Squibb" with 2 trials as a collaborator, "Melanoma Institute Australia" with 2 trials as a collaborator, "Melanoma and Skin Cancer Trials Limited" with 2 trials as a collaborator and "Trans Tasman Radiation Oncology Group" with 2 trials as a collaborator. Other collaborators include 15 different institutions and companies that were
collaborators in the rest 25 trials.
Clinical Trials Conditions at Melanoma Institute Australia
According to Clinical.Site data, the most researched conditions in "Melanoma Institute Australia" are
"Melanoma" (11 trials), "Malignant Melanoma" (3 trials), "Brain Metastases" (2 trials), "Metastatic Melanoma" (2 trials) and "Skin Cancer" (2 trials). Many other conditions were trialed in "Melanoma Institute Australia" in a lesser frequency.
Clinical Trials Intervention Types at Melanoma Institute Australia
Most popular intervention types in "Melanoma Institute Australia" are "Drug" (23 trials), "Biological" (5 trials), "Procedure" (4 trials), "Radiation" (3 trials) and "Other" (2 trials). Other intervention types were less common.
The name of intervention was led by "Nivolumab" (6 trials), "Pembrolizumab" (5 trials), "Ipilimumab" (4 trials), "Placebo" (4 trials) and "Vemurafenib" (3 trials). Other intervention names were less common.
Clinical Trials Genders at Melanoma Institute Australia
The vast majority of trials in "Melanoma Institute Australia" are
32 trials for "All" genders.
Clinical Trials Status at Melanoma Institute Australia
Currently, there are NaN active trials in "Melanoma Institute Australia".
undefined are not yet recruiting,
6 are recruiting,
12 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 12 completed trials in Melanoma Institute Australia,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Melanoma Institute Australia, 9 "Phase 1"
clinical trials were conducted, 15 "Phase 2" clinical
trials and 8 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 4 trials that are defined as “Not Applicable".